| P50 | author | Helena Käyhty | Q111990066 |
| | Merja Väkeväinen | Q124818481 |
| | Terhi Kilpi | Q124818485 |
| | Nina Ekström | Q124818494 |
| P2093 | author name string | Jukka Jokinen | |
| | Jouko Verho | |
| | Heidi Ahman | |
| P2860 | cites work | Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infants | Q24795590 |
| | Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis | Q33818183 |
| | Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides | Q33867137 |
| | Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers | Q33874664 |
| | Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group | Q33896897 |
| | Efficacy of a pneumococcal conjugate vaccine against acute otitis media | Q33932973 |
| | Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants | Q34205630 |
| | Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial | Q34220731 |
| | The V-region repertoire of Haemophilus influenzae type b polysaccharide antibodies induced by immunization of infants | Q34298081 |
| | Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia | Q34917765 |
| | Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conju | Q79162711 |
| | Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age | Q81383639 |
| | Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S | Q35224908 |
| | Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide. | Q35428480 |
| | A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia | Q37013921 |
| | A vaccine carrier derived from Neisseria meningitidis with mitogenic activity for lymphocytes | Q37020603 |
| | Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components | Q37521333 |
| | Effects of misclassification of causes of death on the power of a trial to assess the efficacy of a pneumococcal conjugate vaccine in The Gambia | Q39098911 |
| | Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus-conjugated vaccine: a randomized controlled trial | Q39192944 |
| | The Role of Antibody and Complement in the Reticuloendothelial Clearance of Pneumococci from the Bloodstream | Q40161697 |
| | The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine | Q40552159 |
| | Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants | Q43513640 |
| | Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants | Q43844314 |
| | A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children | Q44922704 |
| | Laboratory correlates of protection against Haemophilus influenzae type b disease. Importance of assessment of antibody avidity and immunologic memory | Q46136264 |
| | A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection | Q46198228 |
| | Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine | Q46849891 |
| | Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines | Q48023963 |
| | Meningococcal serogroup a avidity indices as a surrogate marker of priming for the induction of immunologic memory after vaccination with a meningococcal A/C conjugate vaccine in infants in the United Kingdom. | Q52018218 |
| | Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers. | Q52023272 |
| | Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. | Q52039837 |
| | Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. | Q52039946 |
| | Humoral immunity due to long-lived plasma cells. | Q52040025 |
| | Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens. | Q52041060 |
| | Lifetime of plasma cells in the bone marrow. | Q52042101 |
| | Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines. | Q52048275 |
| | Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children | Q52051185 |
| | Induction of immunologic memory in infants primed with Haemophilus influenzae type b conjugate vaccines. | Q52061178 |
| | Immunogenicity after one, two or three doses and impact on the antibody response to coadministered antigens of a nonavalent pneumococcal conjugate vaccine in infants of Soweto, South Africa | Q63672224 |
| | Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska | Q64132505 |
| | Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines | Q67744447 |
| | The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex | Q67989064 |
| | Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. The Vaccine Study Group | Q68061882 |
| | High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines | Q68128376 |
| | Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants | Q68226933 |
| | Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination | Q69162258 |
| | Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production | Q70018803 |
| | Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants | Q71072124 |
| | Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants | Q71569665 |
| | Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae | Q73264844 |
| | Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants | Q73298427 |
| | Functional antibodies elicited by an 11-valent diphtheria-tetanus toxoid-conjugated pneumococcal vaccine | Q73402133 |
| | Nasopharyngeal carriage of Streptococcus pneumoniae in Finnish children younger than 2 years old | Q74259152 |
| | Carrier-mediated enhancement of cognate T cell help: the basis for enhanced immunogenicity of meningococcal outer membrane protein polysaccharide conjugate vaccine | Q74356870 |
| | Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT | Q74541105 |
| | Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant | Q74615711 |
| | Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered | Q77070691 |
| | Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood | Q77367132 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Finland | Q33 |
| | antibody | Q79460 |
| | vaccine | Q134808 |
| P304 | page(s) | 369-377 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial | |
| P478 | volume | 73 | |